I don't think approval is priced in the current SP.
On approval, it's not only the profit from paediatric indication that should be priced in for valuation purposes, but the platform.
One approval means everything for a platform biotech.
- Forums
- ASX - By Stock
- MSB
- 2024 Here we go again.
2024 Here we go again., page-628
-
-
- There are more pages in this discussion • 176 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.05 |
Change
0.080(8.25%) |
Mkt cap ! $1.198B |
Open | High | Low | Value | Volume |
99.5¢ | $1.06 | 99.0¢ | $4.930M | 4.779M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 23545 | $1.05 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.05 | 339479 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 23545 | 1.045 |
1 | 10000 | 1.040 |
8 | 181213 | 1.035 |
15 | 391706 | 1.030 |
1 | 15570 | 1.025 |
Price($) | Vol. | No. |
---|---|---|
1.050 | 339479 | 5 |
1.055 | 21365 | 3 |
1.060 | 376981 | 13 |
1.065 | 55888 | 5 |
1.070 | 93334 | 6 |
Last trade - 16.10pm 04/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |